Carolinas Wealth Consulting’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-246
Closed -$57.3K 532
2025
Q1
$57.3K Buy
246
+5
+2% +$1.21K 0.01% 331
2024
Q4
$55.3K Buy
241
+9
+4% +$2.06K 0.01% 346
2024
Q3
$51.8K Buy
232
+7
+3% +$1.54K 0.01% 359
2024
Q2
$45.8K Hold
225
0.01% 378
2024
Q1
$49.2K Hold
225
0.01% 377
2023
Q4
$51.1K Buy
225
+5
+2% +$1.05K 0.01% 331
2023
Q3
$43.9K Buy
220
+3
+1% +$633 0.01% 323
2023
Q2
$44.9K Buy
217
+7
+3% +$1.36K 0.01% 362
2023
Q1
$41.3K Hold
210
0.01% 389
2022
Q4
$42.4K Hold
210
0.01% 379
2022
Q3
$37K Hold
210
0.01% 368
2022
Q2
$42K Sell
210
-67
-24% -$14.3K 0.01% 352
2022
Q1
$63K Hold
277
0.01% 317
2021
Q4
$75K Buy
277
+93
+51% +$23K 0.02% 306
2021
Q3
$44K Buy
184
+68
+59% +$17.1K 0.01% 362
2021
Q2
$28K Hold
116
0.01% 446
2021
Q1
$26K Hold
116
0.01% 468
2020
Q4
$20K Buy
+116
New +$20K 0.01% 478

Other funds holding LH

Carolinas Wealth Consulting's LH Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Labcorp (LH) in Q2 2025, closing a stake of 246 shares — an estimated $57.3K sold.

Carolinas Wealth Consulting first reported a position in LH in Q4 2020 and held it in 18 quarters. The position peaked at $75K in Q4 2021. 974 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 246 Labcorp shares in Q2 2025, an estimated $57.3K.
  • Carolinas Wealth Consulting first reported a position in Labcorp in Q4 2020 and held it in 18 quarters.
  • Carolinas Wealth Consulting's Labcorp position peaked at $75K in Q4 2021.
  • 974 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.